Charles Bengtson

About

Charles Bengtson is an Assistant Professor of Medicine at the University of Kansas Medical Center, USA. His research focuses on cystic fibrosis, particularly the role of neutrophil store-operated calcium entry as a biomarker for lung disease progression, and the effects of various modulators on cystic fibrosis transmembrane conductance regulator (CFTR) function. Recent publications include investigations into TGF-β1 inhibition and the impact of losartan on CFTR dysfunction and diabetes associated with cystic fibrosis.